BCR-ABL Tyrosine Kinase Inhibitors May Increase Cardiovascular Events in Chronic Myeloid Leukemia

Contenu connexe

• Projets

• The TiTKI Project - evaluation of the risk of thrombosis associated with the use of tyrosine kinase inhibitors

  Projet: Recherche